Very Negative Take on Matt's Presentation at This Morning's

[mattmatt]

I'm long on this stock and have been in for more than a year with about $150,000 originally invested.  

Some of the popular complaints are:

Lack of Nrx;

Lack of commercials/impotent DTC campaign;

Insurance companies not yet on board; 

Not enough doctors are educated sufficiently about Afrezza (if they have even heard of it at all).

The stock price is embarrassing.

The very standard and tiring response to each one of these is that SNY knows what it is doing and the rollout is a very precisely controlled rollout and is even supported by documents  purportedly put out by SNY showing how they plan to be precise and do the rollout over the long term.  Today Matt, yet again, used such unnecessary language as (paraphrased) "unfortunately, we are not at the numbers we would like to see at this time."  He keeps saying this and it is so damning to the company that I get very angry when I hear it (every conf call).  Here is the rub: If SNY indeed is doing a precise rollout as it is being represented to all of us, then Matt's statements that he wished we were at higher numbers shows to me that either MNKD or SNY or both are behind the ball and things are not going as they expected them to go.  Matt should he saying, taking all available info into account, that we are right on track and that as time goes by and SNY engages new elements of its rollout, things will continue to gain traction and sales will increase, etc etc.

I am thoroughly dissatisfied with the progress, and cannot be anything other than dissatisfied because even Matt believes (or wishes) we should be further along.  What is the real story?  What is SNY's plan?  Damn it, I want to know what the plan is.  There is virtually no reason shareholders should not be given basic information about the plan (I don't mean statements like "we expect some TV ads by the end of 2015).  I want to know what the basic plan is, and I want to hear a progress report.

I wrote Matt an email this week which he quickly answered.  I asked specific questions and he simply said he would try to answer some of the questions during today's conference. He said nothing of any investor value and nothing to suggest anything is improving.

I just don't know if I believe what is in front of me or what everyone says is happening behind the lines... Matt certainly isn't supporting any position that the behind-the-lines actions are well calculated.

Again, I walk away scratching my head.

[falconquest]

Hey, at least we learned what he meant by an "embarrassment of riches"!

[bradleysbest]

That's the frustrating part of this investment. Clearly an innovative treatment for millions of diabetics yet we have sales numbers of 500 after 8 months. Al, MNKD & SNY should be screaming about this product that will help save limbs & life! All we get is another presentation to hang in there..... frustrating !

[harrys]

It actually seemed as if Matt had read this board (unlikely) and was addressing some of the common criticism (embarrassment of riches comment etc.). It definitely seemed like he was flustered (I realize the technical difficulties) and on the defensive. I took Matt's comment once again about not being thrilled with the progress as the last nail in the coffin of the "controlled-launch" theory. I think its now obvious that management (and maybe Sanofi) were completely blindsided by the lack of inertia early on due to a myriad of obstacles (spirometer, label, insurance etc.). The only other explanation for Matt's comment is that he's completely unaware of Sanofi's process and I find that hard to believe considering the joint committee between the two companies.

[vissertrades]

It'S NOT funny. I feel your pain as I have more invested and for much longer. Dysfunctional situation with current management and a billionare owner that is set. Hoping we get there is not good enough, we need measureable milestones and a plan to achieve those goals. Current secrecy has to stop as I feel they can't share what they don't have and that's a problem - BOD should act.

[mnkdorbust]

It's very frustrating, however (I feel / opinion) the current reality is that Sanofi has MNKD and us investors by the genitalia. And since there are so many unknowns who really knows what is going on. As an investor in MNKD before the final Adcom I'm frustrated as well (not to mention underwater). I would hate to be in Matt's position, however for what he's getting paid i would give it one hell of a try. For those complaining about Matt would you rather Haken take the stand? I sure wouldn't.  It's impossible to know what information they have, don't and what they can't talk about.  MNKD has been sued before for saying too much by investors.  It's easy for expectations to get out of whack due to attachment to Afrezza, Al, Technosphere, etc for various reasons especially what potential MNKD and Afrezza have for the ever increasing diabetic population. I've been guilty of it as well. I though for sure by now we would be complaining about not being able to produce enough to meet demand. Unfortunately that isn't the case. And while i'm frustrated i added to my position today as i have been throughout the drop lowering my PPS.

One question i often wonder is when Al invented the insulin pump and it was made available to patients, was it similar to this? Did insurance companies, Doctors, etc. adopt it quickly or did it take time for everyone to become educated on it, finding out about it, adopting it, etc.?

[mssciguy]

Oct 8, 2015 18:20:47 GMT -5 mnkdorbust said:

It's very frustrating, however (I feel / opinion) the current reality is that Sanofi has MNKD and us investors by the genitalia. And since there are so many unknowns who really knows what is going on. As an investor in MNKD before the final Adcom I'm frustrated as well (not to mention underwater). I would hate to be in Matt's position, however for what he's getting paid i would give it one hell of a try. For those complaining about Matt would you rather Haken take the stand? I sure wouldn't.  It's impossible to know what information they have, don't and what they can't talk about.  MNKD has been sued before for saying too much by investors.  It's easy for expectations to get out of whack due to attachment to Afrezza, Al, Technosphere, etc for various reasons especially what potential MNKD and Afrezza have for the ever increasing diabetic population. I've been guilty of it as well. I though for sure by now we would be complaining about not being able to produce enough to meet demand. Unfortunately that isn't the case. And while i'm frustrated i added to my position today as i have been throughout the drop lowering my PPS.

One question i often wonder is when Al invented the insulin pump and it was made available to patients, was it similar to this? Did insurance companies, Doctors, etc. adopt it quickly or did it take time for everyone to become educated on it, finding out about it, adopting it, etc.?

If you want to blame someone for the current stock price, I am almost certain that SNY, MNKD have no involvement with the short/naked short/failure to deliver stock and option manipulation.  The blame falls on certain Wall Street firms and their cabal of dirty hit piece journalists and analysts.  Really, I am beginning to feel a lot of empathy for Matt, Hakan, Al...  what you going to do, go up against Goldman Sachs and it's secret BS?  Can't win, not with the current SEC, sorry

[vissertrades]

Taking the company private? Seems to fit the MO here. Slow roll drains value and shorts help flush it down the drain.

[obamayoumama]

Oct 8, 2015 18:20:47 GMT -5 mnkdorbust said:

It's very frustrating, however (I feel / opinion) the current reality is that Sanofi has MNKD and us investors by the genitalia. And since there are so many unknowns who really knows what is going on. As an investor in MNKD before the final Adcom I'm frustrated as well (not to mention underwater). I would hate to be in Matt's position, however for what he's getting paid i would give it one hell of a try. For those complaining about Matt would you rather Haken take the stand? I sure wouldn't.  It's impossible to know what information they have, don't and what they can't talk about.  MNKD has been sued before for saying too much by investors.  It's easy for expectations to get out of whack due to attachment to Afrezza, Al, Technosphere, etc for various reasons especially what potential MNKD and Afrezza have for the ever increasing diabetic population. I've been guilty of it as well. I though for sure by now we would be complaining about not being able to produce enough to meet demand. Unfortunately that isn't the case. And while i'm frustrated i added to my position today as i have been throughout the drop lowering my PPS.

One question i often wonder is when Al invented the insulin pump and it was made available to patients, was it similar to this? Did insurance companies, Doctors, etc. adopt it quickly or did it take time for everyone to become educated on it, finding out about it, adopting it, etc.?

I thought the important comment by Matt was that SNY is in the process of getting their insulin approved and working on plans for label improvements. If SNY was planning on backing out of the deal, per AF, why would they be trying to get their insulin approved, and planning on trials for label improvement? I guess AF is never going to get a prediction right with MNKD

[bioexec25]

Oct 8, 2015 18:14:20 GMT -5 vissertrades said:

It'S NOT funny. I feel your pain as I have more invested and for much longer. Dysfunctional situation with current management and a billionare owner that is set. Hoping we get there is not good enough, we need measureable milestones and a plan to achieve those goals. Current secrecy has to stop as I feel they can't share what they don't have and that's a problem - BOD should act.

Probably not a popular sentiment, but I believe that the legal contract with SNY prevents Mnkd mgmt from saying anything.  Further as historically this leads to a drop in the target company stock, it is even more strongly enforced especially during a slower launch.  Forward strat plan for some big pharma is to slow roll and use social media and trim there holdings over time versus paying the huge bucks up front.

[mattmatt]

I'm not remotely interested in finding blame for the PPS. I want to know what the actual plan is to move this company into the black. Virtually nothing else. From there, I can decide if this stock is for me. It's not knowing that is killing me

[mnkdorbust]

Oct 8, 2015 18:38:14 GMT -5 obamayoumama said:

Oct 8, 2015 18:20:47 GMT -5 mnkdorbust said:

It's very frustrating, however (I feel / opinion) the current reality is that Sanofi has MNKD and us investors by the genitalia. And since there are so many unknowns who really knows what is going on. As an investor in MNKD before the final Adcom I'm frustrated as well (not to mention underwater). I would hate to be in Matt's position, however for what he's getting paid i would give it one hell of a try. For those complaining about Matt would you rather Haken take the stand? I sure wouldn't.  It's impossible to know what information they have, don't and what they can't talk about.  MNKD has been sued before for saying too much by investors.  It's easy for expectations to get out of whack due to attachment to Afrezza, Al, Technosphere, etc for various reasons especially what potential MNKD and Afrezza have for the ever increasing diabetic population. I've been guilty of it as well. I though for sure by now we would be complaining about not being able to produce enough to meet demand. Unfortunately that isn't the case. And while i'm frustrated i added to my position today as i have been throughout the drop lowering my PPS.

One question i often wonder is when Al invented the insulin pump and it was made available to patients, was it similar to this? Did insurance companies, Doctors, etc. adopt it quickly or did it take time for everyone to become educated on it, finding out about it, adopting it, etc.?

I thought the important comment by Matt was that SNY is in the process of getting their insulin approved and working on plans for label improvements. If SNY was planning on backing out of the deal, per AF, why would they be trying to get their insulin approved, and planning on trials for label improvement? I guess AF is never going to get a prediction right with MNKD

I wasn't implying that i thought Sanofi might back out on the deal.  My opinion is that there seem to be more things MNKD can't talk about than things they can talk about.  I feel it's more strategic than anything likely but nevertheless it's not enjoyable sitting on the sidelines and trying to piece it all together.

[mnkdorbust]

Oct 8, 2015 18:28:09 GMT -5 mssciguy said:

Oct 8, 2015 18:20:47 GMT -5 mnkdorbust said:

It's very frustrating, however (I feel / opinion) the current reality is that Sanofi has MNKD and us investors by the genitalia. And since there are so many unknowns who really knows what is going on. As an investor in MNKD before the final Adcom I'm frustrated as well (not to mention underwater). I would hate to be in Matt's position, however for what he's getting paid i would give it one hell of a try. For those complaining about Matt would you rather Haken take the stand? I sure wouldn't.  It's impossible to know what information they have, don't and what they can't talk about.  MNKD has been sued before for saying too much by investors.  It's easy for expectations to get out of whack due to attachment to Afrezza, Al, Technosphere, etc for various reasons especially what potential MNKD and Afrezza have for the ever increasing diabetic population. I've been guilty of it as well. I though for sure by now we would be complaining about not being able to produce enough to meet demand. Unfortunately that isn't the case. And while i'm frustrated i added to my position today as i have been throughout the drop lowering my PPS.

One question i often wonder is when Al invented the insulin pump and it was made available to patients, was it similar to this? Did insurance companies, Doctors, etc. adopt it quickly or did it take time for everyone to become educated on it, finding out about it, adopting it, etc.?

If you want to blame someone for the current stock price, I am almost certain that SNY, MNKD have no involvement with the short/naked short/failure to deliver stock and option manipulation.  The blame falls on certain Wall Street firms and their cabal of dirty hit piece journalists and analysts.  Really, I am beginning to feel a lot of empathy for Matt, Hakan, Al...  what you going to do, go up against Goldman Sachs and it's secret BS?  Can't win, not with the current SEC, sorry

I personally agree completely.  I was referring to the calls and what we investors are wanting to hear but don't.  

[od]

Oct 8, 2015 18:40:33 GMT -5 bioexec25 said:

Oct 8, 2015 18:14:20 GMT -5 vissertrades said:

It'S NOT funny. I feel your pain as I have more invested and for much longer. Dysfunctional situation with current management and a billionare owner that is set. Hoping we get there is not good enough, we need measureable milestones and a plan to achieve those goals. Current secrecy has to stop as I feel they can't share what they don't have and that's a problem - BOD should act.

Probably not a popular sentiment, but I believe that the legal contract with SNY prevents Mnkd mgmt from saying anything.  Further as historically this leads to a drop in the target company stock, it is even more strongly enforced especially during a slower launch.  Forward strat plan for some big pharma is to slow roll and use social media and trim there holdings over time versus paying the huge bucks up front.

Interesting.  Can you share historical examples?  Thanks bioexec25.

[lynn]

Oct 8, 2015 18:20:47 GMT -5 mnkdorbust said:

]One question i often wonder is when Al invented the insulin pump and it was made available to patients, was it similar to this? Did insurance companies, Doctors, etc. adopt it quickly or did it take time for everyone to become educated on it, finding out about it, adopting it, etc.?

If my memory serves me right I believe Minimed SP was driven down to sub $2's before Medtronic BO , no idea re: insurance adoption but since it was a new technology I'd imagine they had similar hurdles to overcome . Just my 02 cents

Lynn